Antiquités / Mk-2866 Raw Powder CAS 841205-47-8 a good way to build muscle
Détail rapide:
CAS 841205-47-8
Nom du produit: Antiquités,Énobosarm
Alias: Gtx-024,MK-2866
Formule moléculaire: C19H14F3N3O3
Masse moléculaire: 389.3279696
Pureté: 99%
Apparence: Poudre blanche
Classe: Qualité pharmaceutique
La description:
MK-2866 / Énobosarm / Ostarine is a nonsteroidal SARM / selective androgen receptor modulator, that has tissue-selective anabolic effects in muscle and bone, sparing other androgenic tissue related to hair growth in female and prostate effects in male. MK-2866 / Énobosarm / Ostarine is one of the most favorable of any bodybuilding SARMS for being the most anabolic.
You can not campare it to anabolic steroids. But in one aspect, you also see none of the side effects you would see with steroids. MK-2866 / Énobosarm / Ostarine was originally prescribed for the treatment and prevention of muscle wasting. Cancer induced muscle wasting begins early in the course of a patient’s malignant disease. when given to the patients, lean muscle mass was observed.
Application:
Selective androgen receptor modulators may be used by athletes to assist in training and increase physical stamina and fitness, potentially producing effects similar to anabolic steroids.
For research.
Antiquités (MK-2866) est un SARM développé par GTX pour la prévention et le traitement de la gaspillage musculaire. Il pourrait éventuellement être une prescription médicale pour la prévention de la cachexie, atrophy and sarcopenia as well as for Hormone or Replacement Therapy.
En tant que produit chimique, Ostarine appartient à une classe de produits chimiques connus sous le nom de Sarms ou modulateurs sélectifs des récepteurs androgènes. SARMS create selective anabolic activity at certain androgen receptors. In comparison to and other anabolic steroids, L'avantage des sarms, Est-ce qu'ils n'ont pas d'activité androgène dans les tissus musculaires non squelettiques. L'ostarine est efficace pour maintenir et augmenter la masse du corps maigre
Other SARMs
| Nom |
N ° CAS. |
Usage |
| AICAR |
2627-69-2 |
acts by entering nucleoside pools, significantly increasing levels of adenosine
during periods of ATP breakdown |
| MK2866 |
841205-47-8 |
medical prescription for prevention of cachexia, atrophy, and sarcopenia and
for Hormone or Testoserone Replacement Therapy. |
| MK-677 |
15972-10-0 |
for the treatment of frailty in the elderly |
| LGD-4033 |
1165910-22-4 |
pharmacological profile similar to that of enobosarm, Antiquités,MK-2866 |
| GRE1516 |
317318-70-0 |
For obesity, diabète, dyslipidémie et maladies cardiovasculaires |
| Andarine(S4) |
401900-40-0 |
partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
| SR9009 |
1379686-30-2 |
under development at The Scripps Research Institute (DÉTESTER),
augmente le niveau d'activité métabolique dans les muscles squelettiques des souris |
| RAD140 |
1182367-47-0 |
New generation for gaining mass and cutting edges |
| YK11 |
431579-34-9 |
YK11: a SARM and myostatin inhibitor in one
|
| AC262356 |
870888-46-3 |
New SARMS |
| SR9011 |
1379686-29-9 |
New SARMS |
| S23 |
1010396-29-8 |
New SARMS |
| GW0724 |
317318-84-6 |
New SARMS |
Directeur commercial